UTI, a urinary trypsin inhibitor, has been shown to possess anti-inflammatory properties and attenuate LPS-induced acute lung injury (10), inhibit systemic inflammatory responses resulting from pulmonary I/R (11) and alleviate pulmonary I/R injury via the inhibition of TNF-α expression in rats (17). This evidence concerns the gene TNF and injury.